Contracts › 75N93023F00001
75N93023F00001: The Task Order Is to Support Cgmp Manufacturing of the PGT121.414.Ls Monoclonal Antibody (PGT121.414.Ls Mab) Drug Substance From an Established Manufacturing Process, Complete the Fill Finish of the Drug Substance (DS) Into Drug Product (DP), Quality
Awarded to Advanced Bioscience Laboratories, Inc. by National Institutes of Health (NIH).
$17.2Mobligated
$17.2Mpotential value
30 December 2028current end date
See modifications, all subcontractors and funding in FedSift →
| Contract | 75N93023F00001 |
|---|---|
| Vehicle | HHSN272201700010I |
| Awardee | Advanced Bioscience Laboratories, Inc. |
| Awarding agency | National Institutes of Health (NIH) |
| Awarding office | NATIONAL INSTITUTES OF HEALTH NIAID |
| NAICS | 541712 Research and Development in the Physical, Engineering, and Life Sciences (Except Biotechnology) |
| PSC | AN12 Health R&D Services; Health Care Services; Applied Research |
| Place of performance | MD |
| Period of performance | 10 June 2017 to 30 December 2028 |
| Potential end | 30 December 2028 |
| Estimated recompete solicitation | ~Q3 2028 (estimate, ~6 months before expiry) |
Source: USASpending.gov (FPDS), public federal procurement data, as the agency reported it. Our record updated 03 October 2026. The solicitation date is an estimate from the end date, not a posted date.
Other expiring 541712 contracts · All expiring contracts · USASpending record